EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Prevalence of factor V Leiden and factor II 20210A in a large cohort of unselected patients with deep vein thrombosis or pulmonary embolism



Prevalence of factor V Leiden and factor II 20210A in a large cohort of unselected patients with deep vein thrombosis or pulmonary embolism



Circulation 100(18 SUPPL ): I 682, Nov 2




(PDF emailed within 1 workday: $29.90)

Accession: 035548886

Download citation: RISBibTeXText



Related references

Is the prevalence of the factor V Leiden mutation in patients with pulmonary embolism and deep vein thrombosis really different?. Thrombosis and Haemostasis 81(3): 345-348, 1999

Factors V Leiden and II 20210A in patients with symptomatic pulmonary embolism and deep vein thrombosis. American Journal of Medicine 110(1): 12-15, January, 2001

Different risk of deep vein thrombosis and pulmonary embolism in carriers with factor V Leiden compared with non-carriers, but not in other thrombophilic defects. Results from a large retrospective family cohort study. Haematologica 95(6): 1030-1033, 2011

Prevalence of factor V Leiden among women with pulmonary embolism or deep vein thrombosis during pregnancy or oral contraceptive use. Journal of the American College of Cardiology 27(2 SUPPL A): 273A, 1996

Prevalence of factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep venous thrombosis and pulmonary embolism. Clinical and Laboratory Haematology 28(2): 111-116, 2006

Factor V Leiden paradox: risk of deep-vein thrombosis but not of pulmonary embolism. Lancet 356(9225): 182-183, 2000

Role of factor V Leiden or G20210A prothrombin mutation in patients with symptomatic pulmonary embolism and deep vein thrombosis: a meta-analysis of the literature. Journal of Thrombosis and Haemostasis 10(4): 732-737, 2012

PFO closure in high-risk patient with paradoxical arterial embolism, deep vein thrombosis, pulmonary embolism and factor V Leiden genetic mutation. Oxford Medical Case Reports 2018(3): Omx105-Omx105, 2018

Broadening the factor V Leiden paradox: pulmonary embolism and deep-vein thrombosis as 2 sides of the spectrum. Blood 120(5): 933-946, 2012

Sudden hearing loss followed by deep vein thrombosis and pulmonary embolism in a patient with factor V Leiden mutation. International Journal of Audiology 53(9): 625-628, 2015

Comparison of the risk of pulmonary embolism and deep vein thrombosis in the presence of factor V Leiden or prothrombin G20210A. Thrombosis and Haemostasis 83(2): 352-354, 2000

Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: Prevalence of factor V Leiden. American Heart Journal 131(6): 1145-1148, 1996

Relative risk of pulmonary embolism and deep vein thrombosis in association with the factor V Leiden mutation in a United Kingdom population. Thrombosis and Haemostasis 77(6): 1219-1219, 1997

Factor V Leiden paradox and the occurrence of distal vein thrombosis in a large cohort of thrombotic patients. Thrombosis Research 156: 20-22, 2017

Risk factors associated with symptomatic pulmonary embolism in a large cohort of deep vein thrombosis patients. Thrombosis and Haemostasis 93(3): 494-498, 2005